Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Key Blood Markers That Reflect GLP-1 Treatment Success When you begin compounded semaglutide or tirzepatide at PlexusDx, your healthcare team will monitor fasting blood glucose, which typically drops as the medication improves insulin secretion and reduces hepatic glucose production
Hormonal shifts are signs of movement, not malfunction
A., Camus-Randon, A
By developing this in-depth understanding of the impacts of the GLP-1s on patient populations, treatment paradigms and clinician messaging, MedTech companies will be able to make informed strategic decisions to stay the course or pivot to other promising segments if needed
Quick Reference: Standard Protocol Community-documented protocol: 250 mcg subcutaneous in the morning, 3 days per week, for 8-week cycles -- far below the 2.4 mg weekly clinical trial dose, reflecting conservative research-peptide practice
What do these medications do
